Israel-based medical technology company Itamar Medical has secured US Food and Drug Administration (FDA) approval for its WatchPAT, a sleep apnea diagnostic device.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

WatchPAT is a small easy-to-use device which is worn on the wrist and facilitates screening and detection, and is used as a follow-up treatment of obstructive sleep apnea (OSA).

It enables testing to be conducted at the patient's home in an environment which reflects the pattern of the patient's sleep habits.

American Thoracic Society president and University of Chicago and Comer Children's Hospital in Chicago, US pediatric sleep physician and scientist David Gozal said: "The clearance of the WatchPAT for clinical use in adolescents is a welcome addition to the currently limited array of home-based diagnostic technologies for children suspected to suffer from sleep-disordered breathing, and should enable reliable and more timely detection of those patients in need for treatment".

"An early diagnosis of sleep apnea leads to appropriate treatment which can eliminate the chances of unnecessary use of medication."

Sleep apnea leads to the occurrence of attention-deficit hyperactivity disorder (ADHD) in adolescents which cannot be treated until sleep apnea is addressed.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

An early diagnosis of sleep apnea leads to appropriate treatment which can eliminate the chances of unnecessary use of medication.

Building on the strategy of Itamar Medical's strategy of providing a total sleep solution (TSS), WatchPAT measures the pattern of sleep in all stages which are wake, light, deep and rapid eye movement (REM) sleep.

Image: Itamar Medical's WatchPAT sleep apnea diagnostic device. Photo: courtesy of Itamar Medical Ltd.